Drugs / Osvaren Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02027662 | Jan 2014 → Apr 2015 | chronic kidney disease, hyperphosphatemia | Fresenius Medical Care Deutschland GmbH | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Osvaren Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02027662 ↗ |